Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Rationale Studies in humans of cognitive effects of dopaminergic drugs have largely focused on tasks of working memory, with a few studies also examining executive function.Objectives This study was designed to investigate the effects of 1.25 mg of the dopamine D(2) agonist bromocriptine on spatial working memory, planning and discrimination reversal learning in young healthy volunteers.Methods Twenty volunteers were tested in a double-blind, placebo-controlled, cross-over design. The cognitive assessment included tests taken from the Cambridge Neuropsychological Test Automated Battery (CANTAB) designed to test visuo-spatial recognition memory and spatial working memory. In addition, tests of spatial planning and discrimination reversal learning were used to assess the more general effects of bromocriptine. Tests of subjective feelings and motivation were also incorporated into the battery.Results Bromocriptine enhanced the spatial memory span of subjects, whilst impairing their ability to reverse a learned probabilistic discrimination. Tests of recognition memory and planning were unaffected by the drug. The findings were not explained by changes in subjective mood or motivational measures.Conclusions The pattern of findings observed here mirror medication-dependent observations seen in Parkinson's disease. The results are discussed with reference to the different anatomical networks known to subserve performance of the differentially affected tasks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In healthy humans, the D2 receptor antagonist sulpiride enhances reward-based reversal learning (van der Schaaf et al 2014), whereas a D2 receptor agonist bromocriptine impairs probabilistic reversal learning (Mehta et al 2001).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mehta et al 2001
Citations
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 26,755
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388 · cited 1×
“Therefore, Swainson et al. (2000) hypothesised that the impaired reversal learning performance of medicated PD patients resulted from a disrupting “overdosing” of the dopamine innervation to the ventro-medial head of the caudate, which has anatomical connections to the lateral orbito-frontal cortex ( Alexander et al.…”
BackgroundINTERHEMISPHERIC DIFFERENCES IN THE LOCALIZATION OF PSYCHOLOGICAL PROCESSES IN MAN
MILNER, B. (1971) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070866 · Cited by 2,329 · cited 1×
“This test of short-term spatial memory capacity is based on the Corsi Block Tapping Task ( Milner 1971 ).”
MethodThe use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Dissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · cited 2×
“Regions of the lateral prefrontal cortex are known to contribute to visuo-spatial memory performance (Jonides et al. 1993; Baker et al. 1996) and the orbito-frontal cortex is implicated in reversal learning ( Dias et al. 1996 ).”
BackgroundSelf-citationThe two‐period cross‐over clinical trial.
Hills, M., & Armitage, P. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb05903.x · Cited by 1,395 · cited 1×
“This precautionary analysis is advocated by Hills and Armitage (1979) .”
BackgroundD1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364 · cited 1×
“Since direct application of D2 agents into the prefrontal cortex of non-human primates has no effect on delayed-memory performance ( Sawaguchi and Goldman-Rakic 1991, 1994 ), it has been hypothesised that the action of quinpirole at other dopamine receptors (D 3 /D 4 ) or within the striatum may be responsible for its…”
BackgroundPlanning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,245 · cited 8×
“One strategy that is known to be effective ( Owen et al. 1990 ) is to begin each search sequence with a particular box and then, once a token is found, to return to the same starting point and following the same search sequence (removing locations from the sequence when tokens are found).”
BackgroundMethodResultSelf-citationSpatial working memory in humans as revealed by PET
Jonides, J., Smith, E. E., Koeppe, R. A., Awh, E., Minoshima, S., & Mintun, M. A. (1993) · Nature · doi:10.1038/363623a0 · Cited by 1,194 · cited 1×
“Regions of the lateral prefrontal cortex are known to contribute to visuo-spatial memory performance ( Jonides et al. 1993; Baker et al. 1996) and the orbito-frontal cortex is implicated in reversal learning (Dias et al. 1996).”
Background
Cited by
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673
Frank, M. J. (2005) · Journal of Cognitive Neuroscience · doi:10.1162/0898929052880093 · Cited by 925
Cools, R. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1136 · Cited by 906
Cools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903
Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making
Frank, M. J. (2006) · Neural Networks · doi:10.1016/j.neunet.2006.03.006 · Cited by 706
The neural basis of reversal learning: An updated perspective
Izquierdo, A., Brigman, J. L., Radke, A. K., Rudebeck, P. H., & Holmes, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.021 · Cited by 670
“…2006; De Steno and Schmauss, 2009), while either D2/D3 receptor agonists (quinpirole, 7-OH-DPAT) or antagonists (raclopride), impair spatial and olfactory reversals in rats (Boulougouris et al., 2009), monkeys (Smith et al., 1999; Lee et al., 2007) or healthy human volunteers (Mehta et al., 2001).”
BackgroundNeurophysiology of performance monitoring and adaptive behavior
Ullsperger, M., Danielmeier, C., & Jocham, G. (2014) · Physiological Reviews · doi:10.1152/physrev.00041.2012 · Cited by 634
Frank, M. J., & Claus, E. D. (2006) · Psychological Review · doi:10.1037/0033-295x.113.2.300 · Cited by 585
Durstewitz, D., & Seamans, J. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.015 · Cited by 586
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544
Dopamine and Cognitive Control in Prefrontal Cortex
Ott, T., & Nieder, A. (2019) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.12.006 · Cited by 530
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia
Meyer, U., Feldon, J., Schedlowski, M., & Yee, B. K. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.10.012 · Cited by 494
Chudasama, Y., & Robbins, T. W. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.005 · Cited by 484
Self-citationFrank, M. J., & O'Reilly, R. C. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.3.497 · Cited by 472
The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning
Clark, L., Cools, R., & Robbins, T. W. (2004) · Brain and Cognition · doi:10.1016/s0278-2626(03)00284-7 · Cited by 439
Self-citationGenetically Determined Differences in Learning from Errors
Klein, T. A., Neumann, J., Reuter, M., Hennig, J., von Cramon, D. Y., & Ullsperger, M. (2007) · Science · doi:10.1126/science.1145044 · Cited by 426
Prefrontal Serotonin Depletion Affects Reversal Learning But Not Attentional Set Shifting
Clarke, H. F., Walker, S. C., Crofts, H. S., Dalley, J. W., Robbins, T. W., & Roberts, A. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3690-04.2005 · Cited by 358
Self-citationClarke, H., Walker, S., Dalley, J., Robbins, T., & Roberts, A. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj120 · Cited by 351
Self-citationSelective D2 receptor actions on the functional circuitry of working memory
Wang, M., Vijayraghavan, S., & Goldman-Rakic, P. S. (2004) · Science · doi:10.1126/science.1091162 · Cited by 319
Reversal learning as a measure of impulsive and compulsive behavior in addictions
Izquierdo, A., & Jentsch, J. D. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2579-7 · Cited by 295
Lukowski, A. F., Koss, M., Burden, M. J., Jonides, J., Nelson, C. A., Kaciroti, N., Jimenez, E., & Lozoff, B. (2010) · Nutritional Neuroscience · doi:10.1179/147683010x12611460763689 · Cited by 300
L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease
Cools, R., Lewis, S. J. G., Clark, L., Barker, R. A., & Robbins, T. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301153 · Cited by 289
Self-citationChemistry of the mind: Neurochemical modulation of prefrontal cortical function
Robbins, T. W. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20717 · Cited by 292
Self-citationBoosting focally-induced brain plasticity by dopamine
Kuo, M.-F., Paulus, W., & Nitsche, M. A. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm098 · Cited by 269
Chemistry of the adaptive mind
Cools, R., & Robbins, T. W. (2004) · Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2004.1468 · Cited by 257
Self-citationLevodopa: Faster and better word learning in normal humans
Knecht, S., Breitenstein, C., Bushuven, S., Wailke, S., Kamping, S., Flöel, A., Zwitserlood, P., & Ringelstein, E. B. (2004) · Annals of Neurology · doi:10.1002/ana.20125 · Cited by 245
Impulsive and compulsive behaviors in Parkinson's disease
Evans, A. H., Strafella, A. P., Weintraub, D., & Stacy, M. (2009) · Movement Disorders · doi:10.1002/mds.22505 · Cited by 233
Cognitive enhancement by drugs in health and disease
Husain, M., & Mehta, M. A. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.002 · Cited by 241
Self-citationChase, H. W., Swainson, R., Durham, L., Benham, L., & Cools, R. (2011) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2010.21456 · Cited by 223
Self-citationClatworthy, P. L., Lewis, S. J. G., Brichard, L., Hong, Y. T., Izquierdo, D., Clark, L., Cools, R., Aigbirhio, F. I., Baron, J.-C., Fryer, T. D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3266-08.2009 · Cited by 229
Self-citationNolan, K. A., Bilder, R. M., Lachman, H. M., & Volavka, J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.359 · Cited by 222
The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease
Leh, S. E., Petrides, M., & Strafella, A. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.88 · Cited by 209
Barch, D. M., & Carter, C. S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.019 · Cited by 222
Dopaminergic control of cognitive flexibility in humans and animals
Klanker, M., Feenstra, M., & Denys, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00201 · Cited by 209
“While (Mehta et al., 2001) originally observed an increase in non-perseverative errors and slowed reaction times during probabilistic reversal learning after administration of the D2 agonist bromocriptine, Cools et al. (2009) later showed that this drug impaired reversal learning from unexpected…”
BackgroundMehta, M. A., Manes, F. F., Magnolfi, G., Sahakian, B. J., & Robbins, T. W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1899-2 · Cited by 196
Self-citationde Jongh, R., Bolt, I., Schermer, M., & Olivier, B. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.12.001 · Cited by 194
Ventral Striatal Dopamine Modulation of Different Forms of Behavioral Flexibility
Haluk, D. M., & Floresco, S. B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.21 · Cited by 195
Reward/punishment reversal learning in older suicide attempters
Dombrovski, A. Y., Clark, L., Siegle, G. J., Butters, M. A., Ichikawa, N., Sahakian, B. J., & Szanto, K. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030407 · Cited by 193
Self-citationDopamine DRD2 Polymorphism Alters Reversal Learning and Associated Neural Activity
Jocham, G., Klein, T. A., Neumann, J., von Cramon, D. Y., Reuter, M., & Ullsperger, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5195-08.2009 · Cited by 181
Prefrontal cortex executive processes affected by stress in health and disease
Girotti, M., Adler, S. M., Bulin, S. E., Fucich, E. A., Paredes, D., & Morilak, D. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.004 · Cited by 176
Hacking the Brain: Dimensions of Cognitive Enhancement
Dresler, M., Sandberg, A., Bublitz, C., Ohla, K., Trenado, C., Mroczko-Wąsowicz, A., Kühn, S., & Repantis, D. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00571 · Cited by 161
Effects of modafinil on working memory processes in humans
M�ller, U., Steffenhagen, N., Regenthal, R., & Bublak, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1926-3 · Cited by 170
Atallah, H. E., Frank, M. J., & O'Reilly, R. C. (2004) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.06.004 · Cited by 160
Reversal learning and dopamine: a Bayesian perspective
Costa, V. D., Tran, V. L., Turchi, J., & Averbeck, B. B. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1989-14.2015 · Cited by 170
“This work has shown that Parkinson’s disease patients have deficits in reversal learning on medication, but not off (Cools et al., 2001, 2006; Graef et al., 2010) and that manipulating dopamine D2 receptors in the striatum can also lead to deficits (Mehta et al., 2001; Clarke et al., 2011).”
BackgroundEffects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 209
“Both D1 and D2 receptor subtypes are involved in modulating reversal learning in humans, non-human primates, and rodents (Boulougouris et al., 2009; Izquierdo et al., 2006; Lee et al., 2007; Marino et al., 2022; Mehta et al., 2001; Smith et al., 1999; van der Schaaf et al., 2014).”
Computational models of basal-ganglia pathway functions: focus on functional neuroanatomy
Schroll, H., & Hamker, F. H. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00122 · Cited by 134
“Pharmacological studies indeed show that D2 receptor agonists (which predominantly target indirect pathways; cf. section 2.4) impair reversal learning in humans (Mehta et al., 2001).”
BackgroundInfluentialLee, B., Groman, S., London, E. D., & Jentsch, J. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301337 · Cited by 148
Reward, interrupted: Inhibitory control and its relevance to addictions
Jentsch, J. D., & Pennington, Z. T. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.022 · Cited by 134
“First, while it is a predominantly consistent finding that drugs targeting D2-like receptors alter indices of inhibitory control, the direction of this relationship is sometimes ambiguous, with agonists and antagonists producing both decrements and enhancements in performance (Besson et al., 2010; Boulougouris et al.,…”
BackgroundDopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleus
Clarke, H. F., Hill, G. J., Robbins, T. W., & Roberts, A. C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5066-10.2011 · Cited by 144
Self-citationInfralimbic D2 Receptors Are Necessary for Fear Extinction and Extinction-Related Tone Responses
Mueller, D., Bravo-Rivera, C., & Quirk, G. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.014 · Cited by 136
MacDonald, P. A., & Monchi, O. (2011) · Parkinson s Disease · doi:10.4061/2011/572743 · Cited by 141
Human cognitive flexibility depends on dopamine D2 receptor signaling
van Holstein, M., Aarts, E., van der Schaaf, M. E., Geurts, D. E. M., Verkes, R. J., Franke, B., van Schouwenburg, M. R., & Cools, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2340-2 · Cited by 151
MacDonald, P. A., MacDonald, A. A., Seergobin, K. N., Tamjeedi, R., Ganjavi, H., Provost, J.-S., & Monchi, O. (2011) · Brain · doi:10.1093/brain/awr075 · Cited by 122
Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys
Seu, E., Lang, A., Rivera, R. J., & Jentsch, J. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1250-4 · Cited by 131
The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression
McLean, A., Rubinsztein, J. S., Robbins, T. W., & Sahakian, B. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1586-8 · Cited by 125
Self-citationLi, B., Arime, Y., Hall, F. S., Uhl, G. R., & Sora, I. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.036 · Cited by 120
The role of prefrontal catecholamines in attention and working memory
Clark, K. L., & Noudoost, B. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00033 · Cited by 100
Carbon, M., Ma, Y., Barnes, A., DHAWAN, V. M., Chaly, T., Ghilardi, M. F., & Eidelberg, D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.12.014 · Cited by 122
Dopamine Modulates Adaptive Prediction Error Coding in the Human Midbrain and Striatum
Diederen, K. M. J., Ziauddeen, H., Vestergaard, M. D., Spencer, T., Schultz, W., & Fletcher, P. C. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1979-16.2016 · Cited by 110
“Studies that observed a significant effect of bromocriptine typically used lower doses (Mehta et al., 2001; Morcom et al., 2010; Medic et al., 2014).”
BackgroundCsomor, P., Stadler, R. R., Feldon, J., Yee, B. K., Geyer, M. A., & Vollenweider, F. X. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301421 · Cited by 116
Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
Young, J., & Geyer, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555252 · Cited by 110
“Although there is limited evidence for nicotine improving traditional measures of working memory in humans, the same D2 family agonist improved human spatial working memory span capacity in subjects with poor span capacity (Gibbs and D’esposito, 2006; Mehta et al., 2001).”
BackgroundCatecholamines and cognition after traumatic brain injury
Jenkins, P. O., Mehta, M. A., & Sharp, D. J. (2016) · Brain · doi:10.1093/brain/aww128 · Cited by 107
“The ventral portion of the striatum is vulnerable to ‘overdosing’ with dopamine medication as it is relatively spared of dopaminergic deficit in the early stages of Parkinson’s disease, but may be similarly vulnerable in healthy volunteers (Mehta et al., 2001).”
BackgroundSelf-citationDopamine and the motivation of cognitive control
Cools, R., Froböse, M. I., Aarts, E., & Hofmans, L. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804281-6.00007-0 · Cited by 107
Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition
Braskie, M. N., Wilcox, C. E., Landau, S. M., O’Neil, J. P., Baker, S. L., Madison, C. M., Kluth, J. T., & Jagust, W. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3729-08.2008 · Cited by 102
The Dopamine System and the Pathophysiology of Schizophrenia: A Basic Science Perspective
Goto, Y., & Grace, A. A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78002-3 · Cited by 108
Relative lack of cognitive effects of methylphenidate in elderly male volunteers
Clark, L., Aron, A. R., Dowson, J. H., Sahakian, B. J., Turner, D. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1457-3 · Cited by 97
Self-citationDang, L. C., Samanez-Larkin, G. R., Castrellon, J. J., Perkins, S. F., Cowan, R. L., NEWHOUSE, P. A., & Zald, D. H. (2017) · eNeuro · doi:10.1523/eneuro.0211-17.2017 · Cited by 93
“Bromocriptine was administered at a dose of 1.25 mg, a typical amount used in studies of bromocriptine effects on humans (Mehta et al., 2001; Cools et al., 2007; McAllister et al., 2011).”
BackgroundInfluentialFrom symphony to cacophony: Pathophysiology of the human basal ganglia in Parkinson disease
Gale, J. T., Amirnovin, R., Williams, Z. M., Flaherty, A. W., & Eskandar, E. N. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.11.005 · Cited by 102
Millan, M. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.002 · Cited by 99
Dopaminergic Enhancement of Cognitive Function
Mehta, M., & Riedel, W. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698891 · Cited by 91
Self-citationGibbs, S. E. B., & D'Esposito, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0077-5 · Cited by 88
Pharmacological manipulation of human working memory
Barch, D. M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1732-3 · Cited by 99
Tonic Dopaminergic Stimulation Impairs Associative Learning in Healthy Subjects
Breitenstein, C., Korsukewitz, C., Flöel, A., Kretzschmar, T., Diederich, K., & Knecht, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301167 · Cited by 93
Dopamine gene predicts the brain's response to dopaminergic drug
Cohen, M. X., Krohn‐Grimberghe, A., Elger, C. E., & Weber, B. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05947.x · Cited by 93
Tanaka, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.070 · Cited by 88
Serotonergic and dopaminergic modulation of attentional processes
Boulougouris, V., & Tsaltas, E. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00925-4 · Cited by 82
Dosage-Dependent Effect of Dopamine D2 Receptor Activation on Motor Cortex Plasticity in Humans
Fresnoza, S. M., Stiksrud, E. M., Klinker, F., Liebetanz, D., Paulus, W., Kuo, M., & Nitsche, M. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0832-14.2014 · Cited by 82
“…heterogeneous effects on cognitive functions in humans (Luciana et al., 1992; Kimberg et al., 1997; Luciana and Collins, 1997; Müller et al., 1998; Mehta et al., 2001) including improvement, it might also be argued that state-dependent heterogeneous optimal physiological levels of D2 activity do…”
BackgroundImaging the genetics of executive function
Greene, C. M., Braet, W., Johnson, K. A., & Bellgrove, M. A. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2007.11.009 · Cited by 95
Ko, J. H., Ptito, A., Monchi, O., Cho, S. S., van Eimeren, T., Pellecchia, G., Ballanger, B., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.02.031 · Cited by 81
Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans
Papaleo, F., Burdick, M., Callicott, J. H., & Weinberger, D. R. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.133 · Cited by 78
Working Memory Capacity Predicts Effects of Methylphenidate on Reversal Learning
van der Schaaf, M. E., Fallon, S. J., ter Huurne, N., Buitelaar, J. K., & Cools, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.100 · Cited by 80
Memory Encoding and Dopamine in the Aging Brain: A Psychopharmacological Neuroimaging Study
Morcom, A. M., Bullmore, E. T., Huppert, F. A., Lennox, B., Praseedom, A., Linnington, H., & Fletcher, P. C. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp139 · Cited by 78
Dodds, C. M., Clark, L., Dove, A., Regenthal, R., Baumann, F., Bullmore, E., Robbins, T. W., & Müller, U. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1634-0 · Cited by 66
Self-citationMehta, M. A., Montgomery, A. J., Kitamura, Y., & Grasby, P. M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0947-0 · Cited by 71
Self-citationA neuronal mechanism underlying decision-making deficits during hyperdopaminergic states
Verharen, J. P. H., de Jong, J. W., Roelofs, T. J. M., Huffels, C. F. M., van Zessen, R., Luijendijk, M. C. M., Hamelink, R., Willuhn, I., den Ouden, H. E. M., van der Plasse, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03087-1 · Cited by 62
Mäkelä, P., Wakeley, J., Gijsman, H. J., Robson, P. J., Bhagwagar, Z., & Rogers, R. D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300871 · Cited by 70
Striatal Dopamine Influences the Default Mode Network to Affect Shifting between Object Features
Dang, L. C., Donde, A., Madison, C. M., O’Neil, J. P., & Jagust, W. J. (2012) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00252 · Cited by 67
“relationships between high dopamine and low performance have proposed an “overdosing” effect whereby high dopamine is indicative of a deviation from the optimal dopamine level and thus optimal performance (Cools et al., 2001; Mehta, Swainson, Ogilvie, Sahakian, & Robbins, 2001 ).”
A role for dopamine D2 receptors in reversal learning
DeSteno, D. A., & Schmauss, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.052 · Cited by 69
Effects of dopamine‐related gene–gene interactions on working memory component processes
Stelzel, C., Basten, U., Montag, C., Reuter, M., & Fiebach, C. J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06647.x · Cited by 60
Mehta, M. A., Hinton, E. C., Montgomery, A. J., Bantick, R. A., & Grasby, P. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048889 · Cited by 63
Self-citationMehta, M. A., McGowan, S., Lawrence, A. D., Aitken, M. R. F., Montgomery, A. J., & Grasby, P. M. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.08.007 · Cited by 66
Self-citationDifferential Influence of Levodopa on Reward-Based Learning in Parkinson's Disease
Graef, S., Biele, G., Krugel, L. K., Marzinzik, F., Wahl, M., Wotka, J., Klostermann, F., & Heekeren, H. R. (2010) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2010.00169 · Cited by 66
The physiological basis of clinical deficits in Parkinson’s disease
McAuley, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00003-0 · Cited by 62
The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.
Liggins, J., Pihl, R. O., Benkelfat, C., & Leyton, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028370 · Cited by 58
“[101] 20 VAS Q Bromocriptine Q VAS Contented and q VAS Sad and”
BackgroundKarlsgodt, K. H., Bachman, P., Winkler, A. M., Bearden, C. E., & Glahn, D. C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.016 · Cited by 63
Mehta, M. A., Gumaste, D., Montgomery, A. J., McTavish, S. F. B., & Grasby, P. M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2128-8 · Cited by 66
Self-citationCNTRICS Final Task Selection: Long-Term Memory
Ragland, J. D., Cools, R., Frank, M. J., Pizzagalli, D. A., Preston, A. R., Ranganath, C., & Wagner, A. D. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn134 · Cited by 60
Huben, S. N. V., Davis, S. A., Lay, C. C., Katner, S. N., Crean, R. D., & Taffe, M. A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0347-x · Cited by 61
Morein-Zamir, S., Craig, K. J., Ersche, K. D., Abbott, S., Muller, U., Fineberg, N. A., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1963-z · Cited by 54
Self-citationInvestigation of serotonin-1A receptor function in the human psychopharmacology of MDMA
Hasler, F., Studerus, E., Lindner, K., Ludewig, S., & Vollenweider, F. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108094650 · Cited by 52
Metadata
- Authors
- Mehta, M. A., Swainson, R., Ogilvie, A. D., Sahakian, B., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Venue
- Psychopharmacology
- Published
- 2001-09-11
- Volume
- 159
- Issue
- 1
- Pages
- 10-20
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2060886872
- Cited by
- 235
- References
- 33
- Citations by year
- 2025: 5 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 1 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 4 · 2016: 15 · 2015: 6 · 2014: 13 · 2013: 14 · 2012: 11
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- bromocriptine, spatial working memory, reversal learning, discrimination reversal, spatial planning, executive function, Parkinson's disease, dopaminergic therapy, subjective motivation
- MeSH terms
- Adult, Analysis of Variance, Bromocriptine, Double-Blind Method, Humans, Male, Memory, Short-Term, Neuropsychological Tests, Reaction Time, Reversal Learning, Receptors, Dopamine D2, Dopamine Agonists, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.